Skip to main content

Table 4 KEGG analysis of leukemia related pathways

From: Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells

KEGG term ID Input number Background number Regulated Genes
Chronic myeloid leukemia hsa05220 4 73 up CRK, CHUK, NFKB1, NRAS
6 73 down STAT5B, MAP 2 K2, PIK3CD, GAB2, SHC2, MAPK3
Acute myeloid leukemia hsa05221 4 57 up KIT, CHUK, NFKB1, NRAS
8 57 down PPARD, MAP2K2, SPI1, PIM1, PIK3CD, STAT5B, MAPK3, STAT3
Hematopoietic cell lineage hsa04640 4 88 up KIT, CD44, THPO, ITGA3
9 88 down ITGAM, ITGA2B, CD19, ANPEP, CD33, CD7, IL9R, CD37, ITGA5
Human T-cell leukemia virus 1 infection hsa05166 17 261 up PCNA, ANAPC10, CDC23, NFKB1, POLE3, FOSL1, ATR, VAC14, CDC26, CHUK, ETS2, POLE4, RANBP1, VDAC3, MRAS, CREM, NRAS
22 261 down STAT5B, HLA-E, TP53INP1, HLA-A, NFATC2, TNFRSF13C, FZD4, FZD2, IL15RA, PIK3CD, TLN1, NFATC4, HLA-B, WNT11, ATF3, SPI1, RRAS, MAP3K3, WNT6, HLA-C, TSPO, SLC25A6